Taj Group Investor Update
Quality Medicines Diseases Newsroom Feed back Contact us


Investor Update Book
Investor Updates


To receive the Taj updates electronically, please Click here.

Apr, 12 Taj pharmaceuticals and GlaxoSmithKline announce promotion agreement for Ban Labs in the Mumbai more..
Apr, 6 No Vacancy for C & F Agent in India more..
World in HandMoneyCollabrationvision
  Company   Products   Diseases   Health   Media   R & D   Sustainability  
  Figure & Reports   Investors   Countries   E-mail us      Divisions   Contact us   Home  

         Copyright 2005 TAJ Pharmaceuticals Limited ,434 LAXMI PLAZA (LAXMI INDUSTRIAL ESTATE) NEW LINK ROAD Andheri (W) MUMBAI-53. INDIA

Site Requirements : Internet Explorer 5.0+ or Netscape 5.0+, Flash Player 5.0 & Real Player 8 Basic
To get in touch with us, call on 91-22-2637 4592, 91--22-2637 4593 or fax us at 91-22-2634 1274 

| Privacy Policy | Terms & Conditions | Sitemap |